Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
<p>Abstract</p> <p>Background</p> <p>To assess acute (primary endpoint) and late toxicity, quality of life (QOL), biochemical or clinical failure (secondary endpoints) of a hypofractionated IMRT schedule for prostate cancer (PC).</p> <p>Methods</p> <...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-08-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/2/1/29 |